WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) II L.P. reported 1 transaction at UPSTREAM BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/15/2024ACC: 0000950170-24-114802
→
10% Owner
Since Oct 2024
+41.79K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
894.73K acquired · 852.94K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+894.73K
Price / share
—
Trade value
—
% of position
New position
10/15/2024
0.00→894.73K
Total
Net shares
+894.73K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/15/2024 | C · Conversion | +894.73K | — | — | New position | 0.00 | 894.73K |
| Total | +894.73K | $0.00 | ||||||
Derivative Transactions1
Series B redeemable convertible preferred stock
Direct
Converts to
Common Stock
894.73K shares
Shares
−852.94K
Strike price
Held after
0.00
Exercisable
—
10/15/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B redeemable convertible preferred stock Direct | Common Stock894.73K shares | 10/15/2024 | C · Conversion | −852.94K | — | 0.00 |